Final survival analysis of the double-blind, randomized, multinational phase III trial of letrozole (Femara®) compared to tamoxifen as first-line hormonal therapy for advanced breast cancer

Breast Cancer Research and Treatment

Volumn 69, Issue 3, 2001, Pages 211-

  Mouridsen, H ^a   Sun, Y ^a   Gershanovich, M ^a   Perez Carrion, R ^a   Smith, R ^a   Chaudri Ross, H A ^a   Lang, R ^a   Brady, C ^a   Dugan, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749093806     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)